Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk ...

ETFs that give that give retail investors magnified exposure to individual stocks are booming. That could be an ominous sign ...

Defiance ETFs introduces NVOX, a leveraged ETF offering 2X exposure to Novo Nordisk's stock price movements, targeting the ...

Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum Defiance ETFs introduces NVOX, a leveraged ETF offering 2X exposure to Novo Nordisk's ...

There is no Morningstar’s Analysis data available. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

NVOX Disclosure: Defiance ETFs LLC is the ETF sponsor. The Fund’s investment adviser is Tidal Investments, LLC (“Tidal” or the “Adviser”). The Fund’s investment objectives, risks ...

Bank of America believes strong economic growth will support further broadening of the stock market rally in 2025. The tech sector bounces back, with the Technology Select Sector SPDR Fund (XLK ...

MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss ...

With 2025 quickly approaching, Wealth! Host Brad Smith takes a look at the best and worst performers of the S&P 500 since the start of 2024. The top-performing stocks in the index include Vistra (VST) ...